Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.21.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2021
May 17, 2021
Cover [Abstract]    
Entity Registrant Name ENDONOVO THERAPEUTICS, INC.  
Entity Central Index Key 0001528172  
Document Type 10-Q  
Document Period End Date Mar. 31, 2021  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business Flag true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   60,459,771
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2021